[Lipoprotein (a), atherosclerosis, and diabetes mellitus]. 1994

M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
Unidad de Diabetes y Lipidos, Hospital Universitario San Carlos, Facultad de Medicina Universidad Complutense, Madrid, España.

Diabetes mellitus is associated with a three to fourfold increased risk for coronary artery disease and diabetic patients frequently have an abnormal plasma lipid profile. Lately, lipoprotein (a) has received attention as an important independent risk factor for cardiovascular disease. This lipoprotein is elevated in patients with type II diabetes mellitus and there may be an association between the metabolic control of these subjects and its levels. In this review the main features of lipoprotein (a) and its relationship to the fibrinolytic system and atherosclerosis are reviewed.

UI MeSH Term Description Entries
D008297 Male Males
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 1952, Diabetes,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 1994, Journal of internal medicine. Supplement,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
February 1987, Metabolism: clinical and experimental,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 1997, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
April 1995, Diabete & metabolisme,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
May 2022, Atherosclerosis,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
August 1997, Diabetic medicine : a journal of the British Diabetic Association,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 1989, British medical bulletin,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 1969, Medicinski arhiv,
M T Martínez, and F Pérez, and M Calvillán, and M D Gutiérrez-López, and M Serrano-Ríos
January 2011, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!